FluoroPharma Medical Inc
OTC:FPMI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FluoroPharma Medical Inc
OTC:FPMI
|
US |
|
Fusion Pharm Inc
OTC:FSPM
|
US |
|
S
|
Sichuan Discovery Dream Science & Technology Co Ltd
SZSE:301213
|
CN |
|
Oversea-Chinese Banking Corporation Ltd
OTC:OVCHY
|
SG |
|
Aura Energy Ltd
LSE:AURA
|
AU |
Income Statement
Earnings Waterfall
FluoroPharma Medical Inc
Income Statement
FluoroPharma Medical Inc
| Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
|
| Revenue |
0
N/A
|
0
-41%
|
0
-60%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-100%
|
(0)
-50%
|
(0)
+33%
|
(0)
N/A
|
(0)
-700%
|
(0)
-113%
|
(1)
-53%
|
(1)
-71%
|
(1)
-6%
|
(3)
-186%
|
(3)
-10%
|
(3)
-11%
|
(4)
-23%
|
(3)
+27%
|
(4)
-19%
|
(4)
-19%
|
(4)
-3%
|
(5)
-5%
|
(4)
+2%
|
(4)
+1%
|
(5)
-4%
|
(5)
-3%
|
(5)
-12%
|
(5)
+1%
|
(5)
+7%
|
(4)
+10%
|
(4)
+16%
|
(3)
+12%
|
(3)
+6%
|
(3)
+1%
|
(3)
+15%
|
(2)
+13%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
1
|
2
|
1
|
2
|
(0)
|
(0)
|
0
|
0
|
1
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
N/A
|
(0)
-50%
|
(0)
+33%
|
(0)
N/A
|
(0)
-750%
|
(0)
-106%
|
(1)
-54%
|
(1)
-76%
|
(1)
-6%
|
(3)
-171%
|
(3)
-9%
|
(3)
-9%
|
(4)
-18%
|
(3)
+28%
|
(3)
-20%
|
(4)
-20%
|
(4)
-4%
|
(4)
-6%
|
(5)
-2%
|
(6)
-24%
|
(6)
-6%
|
(7)
-13%
|
(7)
+1%
|
(4)
+38%
|
(3)
+18%
|
(3)
+14%
|
(2)
+38%
|
(3)
-77%
|
(4)
-32%
|
(3)
+17%
|
(3)
+8%
|
(2)
+36%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(4)
|
(3)
|
(3)
|
(2)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
N/A
|
(0)
-50%
|
(0)
+33%
|
(0)
N/A
|
(0)
-750%
|
(0)
-106%
|
(1)
-54%
|
(1)
-76%
|
(1)
-6%
|
(4)
-256%
|
(4)
-8%
|
(4)
-9%
|
(5)
-15%
|
(3)
+39%
|
(4)
-19%
|
(4)
-18%
|
(4)
-4%
|
(5)
-6%
|
(6)
-32%
|
(7)
-20%
|
(8)
-6%
|
(9)
-11%
|
(7)
+16%
|
(5)
+35%
|
(4)
+16%
|
(3)
+12%
|
(2)
+32%
|
(4)
-58%
|
(5)
-26%
|
(4)
+15%
|
(4)
+7%
|
(3)
+31%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.39
-3 800%
|
-0.08
+79%
|
-0.08
N/A
|
-0.07
+12%
|
-0.3
-329%
|
-0.18
+40%
|
-0.24
-33%
|
-0.21
+13%
|
-0.13
+38%
|
-0.16
-23%
|
-0.18
-12%
|
-0.19
-6%
|
-0.2
-5%
|
-0.25
-25%
|
-0.3
-20%
|
-0.27
+10%
|
-0.29
-7%
|
-0.24
+17%
|
-0.16
+33%
|
-0.13
+19%
|
-0.11
+15%
|
-0.07
+36%
|
-0.12
-71%
|
-0.15
-25%
|
-0.12
+20%
|
-0.04
+67%
|
-0.08
-100%
|
|